SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 11/21/2017 11:15:21 AM - Followers: 215 - Board type: Free - Posts Today: 2

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.

 

CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.

 
ADJUVANT PIPELINE:

 

 
CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243

 
SureTrader
Interactive Brokers Advertisement
NVAX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX News: Statement of Changes in Beneficial Ownership (4) 11/13/2017 08:16:53 AM
NVAX News: Statement of Changes in Beneficial Ownership (4) 11/13/2017 08:15:03 AM
NVAX News: Novavax to Present at the Stifel 2017 Healthcare Conference 11/08/2017 04:05:24 PM
NVAX News: Novavax to Present at the Stifel 2017 Healthcare Conference 11/08/2017 04:05:00 PM
NVAX News: Current Report Filing (8-k) 11/07/2017 04:36:53 PM
PostSubject
#4937   Awesome last few weeks. About 30-40 million Alyssa 11/21/17 11:15:21 AM
#4936   NVAX BLUE SKIES AFTER 1.40 imapro 11/21/17 09:35:16 AM
#4935   * * $NVAX Video Chart 11-20-17 * * ClayTrader 11/20/17 05:13:59 PM
#4934   This could be the option play of the WovenO2 11/20/17 03:23:49 PM
#4933   SQUEEZE bleu22 11/20/17 02:54:20 PM
#4932   NVAX is going up the stairs. Keep climbing. Dgoff 11/17/17 05:59:02 PM
#4931   Great week! gastric 11/17/17 05:49:18 PM
#4930   30 days after the "insider" CEO last bought shares tiv111 11/17/17 04:54:36 PM
#4929   I wonder when we get the news! the gipper 11/17/17 04:09:52 PM
#4928   $1.13/ share 100,000 shares acquired by CEO, Nice sorkin 11/17/17 03:07:00 PM
#4927   $NVAX gigantic insider buy (CEO) sorkin 11/17/17 03:05:22 PM
#4926   TEVA had outstanding run Your call was on the money sorkin 11/17/17 03:02:55 PM
#4925   Agreed. :-) WovenO2 11/17/17 02:43:41 PM
#4924   Going to $2 sorkin 11/17/17 11:02:09 AM
#4923   Going to $2 sorkin 11/17/17 11:00:01 AM
#4922   Oh yeah! Sure looks like shorts are the gipper 11/17/17 10:31:40 AM
#4921   Bought this a few times in beginning of Santo 11/17/17 10:25:53 AM
#4920   Gotta love a good squeeze in the morning. bleu22 11/17/17 10:15:48 AM
#4919   Bought 10k shares yesterday what are we looking don estaban 11/17/17 10:06:31 AM
#4918   Overall, it was a good week... Santo 11/17/17 09:36:33 AM
#4917   LMAO bleu22 11/17/17 08:52:14 AM
#4916   I guess after it closed at 1.16 on Gup80 11/17/17 07:59:52 AM
#4915   too funny bleu22! That is rather strange the gipper 11/16/17 08:53:26 PM
#4914   We’re is CT and his chart, LMAO he bleu22 11/16/17 07:10:43 PM
#4913   Looking good, hopefully next short wall falls soon. bleu22 11/16/17 02:21:09 PM
#4912   At this level, we're engulfing the last three Syzygenic 11/16/17 01:24:08 PM
#4911   Just saw 250k+ on the ask @ 1.20 the gipper 11/16/17 01:07:07 PM
#4910   Agree with everything you say...especially positive outlook regarding Gup80 11/16/17 09:02:02 AM
#4909   I've always felt pre-market trading was irrational and Syzygenic 11/16/17 08:35:06 AM
#4908   ????? After watching the shenanigans of the last Gup80 11/16/17 08:20:15 AM
#4907   Shorty trying to cover on low volume, this bleu22 11/15/17 11:19:12 AM
#4906   * * $NVAX Video Chart 11-14-17 * * ClayTrader 11/14/17 04:38:32 PM
#4905   Shorties are about to get stuck. Running out bleu22 11/14/17 03:32:12 PM
#4904   Insider buying. Two form 4s posted yesterday. One Saskey 11/14/17 07:43:58 AM
#4903   Interesting sorkin 11/14/17 07:29:30 AM
#4902   https://www.bizjournals.com/washington/news/2017/11/08/novavax-in-position-to-se rulestocks 11/13/17 09:38:15 PM
#4901   * * $NVAX Video Chart 11-13-17 * * ClayTrader 11/13/17 05:26:36 PM
#4900   Today's volume so far is more than twice Alyssa 11/13/17 01:38:14 PM
#4899   No doubt news on the horizon. Looks to bleu22 11/13/17 11:31:42 AM
#4898   bleu22---that would be sweet. Insider buying large the gipper 11/13/17 11:19:31 AM
#4897   Yes it does. Shorts covering? There Alyssa 11/13/17 10:59:12 AM
#4896   It’s nice to c some green. Would love bleu22 11/13/17 10:59:09 AM
#4895   I see we have two buyers, actually. Syzygenic 11/13/17 08:31:22 AM
#4894   CEO buys 100k @ 1.13.....That is what you the gipper 11/13/17 08:23:38 AM
#4893   It looks like something is afoot this morning. Syzygenic 11/13/17 08:23:28 AM
#4892   NVAX has deliverables targeted for mid '18 that Gup80 11/09/17 03:23:15 PM
#4891   Thank you for that Gup80. They need to Dgoff 11/09/17 02:52:57 PM
#4890   When they release the choke hold it could Gup80 11/09/17 02:28:28 PM
#4889   Q3.. positive..negative..or neutral? Is there other reasons for Dgoff 11/08/17 07:17:01 AM
#4888   10Q available: Revenue increased, expenses decreased, still running gastric 11/07/17 09:58:56 PM
PostSubject